Sarepta Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Sarepta Therapeutics (NASDAQ:SRPT), a leader in precision genetic medicine for rare diseases, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. The company's senior management will deliver a presentation on Monday, January 13, 2025, at 12:00 p.m. ET / 9:00 a.m. PT.
The presentation will be followed by a Q&A session starting at 12:20 p.m. ET / 9:20 a.m. PT. Investors and interested parties can access the live webcast through the Events & Presentations section of Sarepta's investor relations website. The presentation recording will remain available on the website for 90 days afterward. Attendees are advised to connect early to allow time for any necessary software downloads.
Sarepta Therapeutics (NASDAQ:SRPT), un leader nella medicina genetica di precisione per malattie rare, ha annunciato la sua partecipazione alla 43ª Conferenza Sanitaria Annuale J.P. Morgan a San Francisco. La direzione senior dell'azienda presenterà un intervento lunedì 13 gennaio 2025, alle 12:00 ET / 9:00 PT.
La presentazione sarà seguita da una sessione di domande e risposte che inizierà alle 12:20 ET / 9:20 PT. Gli investitori e le parti interessate possono accedere al webcast live attraverso la sezione Eventi e Presentazioni del sito web per le relazioni con gli investitori di Sarepta. La registrazione della presentazione rimarrà disponibile sul sito per 90 giorni dopo. Si consiglia ai partecipanti di connettersi in anticipo per consentire tempo per eventuali download di software necessari.
Sarepta Therapeutics (NASDAQ:SRPT), un líder en medicina genética de precisión para enfermedades raras, ha anunciado su participación en la 43ª Conferencia Anual de Atención Médica de J.P. Morgan en San Francisco. La alta dirección de la compañía realizará una presentación el lunes 13 de enero de 2025, a las 12:00 p.m. ET / 9:00 a.m. PT.
La presentación será seguida de una sesión de preguntas y respuestas que comenzará a las 12:20 p.m. ET / 9:20 a.m. PT. Los inversores y partes interesadas pueden acceder a la transmisión en vivo a través de la sección de Eventos y Presentaciones en el sitio web de relaciones con inversores de Sarepta. La grabación de la presentación estará disponible en el sitio durante 90 días después. Se aconseja a los asistentes conectarse con anticipación para permitir tiempo para cualquier descarga de software necesaria.
사레프타 치료제 (NASDAQ:SRPT)는 희귀 질환을 위한 정밀 유전자 의학 분야의 선두주자로서 샌프란시스코에서 열리는 제43회 J.P. 모건 헬스케어 컨퍼런스에 참석할 것이라고 발표했습니다. 회사의 고위 경영진은 2025년 1월 13일 월요일 오후 12시(ET) / 오전 9시(PT)에 발표를 진행합니다.
발표 후에는 오후 12시 20분(ET) / 오전 9시 20분(PT)부터 Q&A 세션이 진행됩니다. 투자자 및 이해관계자는 사레프타의 투자자 관계 웹사이트의 이벤트 및 발표 섹션을 통해 라이브 웹캐스트에 접속할 수 있습니다. 발표 녹화본은 그 후 90일 동안 웹사이트에서 제공됩니다. 참석자들은 필요한 소프트웨어 다운로드 시간을 고려하여 미리 접속할 것을 권장합니다.
Sarepta Therapeutics (NASDAQ:SRPT), un leader dans la médecine génétique de précision pour les maladies rares, a annoncé sa participation à la 43e Conférence Annuelle sur les Soins de Santé J.P. Morgan à San Francisco. La direction senior de l'entreprise fera une présentation le lundi 13 janvier 2025, à 12h00 ET / 9h00 PT.
La présentation sera suivie d'une session de questions-réponses qui commencera à 12h20 ET / 9h20 PT. Les investisseurs et les parties intéressées peuvent accéder à la diffusion en direct via la section Événements & Présentations du site web des relations investisseurs de Sarepta. L'enregistrement de la présentation restera disponible sur le site pendant 90 jours par la suite. Les participants sont conseillés de se connecter à l'avance pour permettre le téléchargement de tout logiciel nécessaire.
Sarepta Therapeutics (NASDAQ:SRPT), ein führendes Unternehmen in der präzisen Gentherapie für seltene Krankheiten, hat seine Teilnahme an der 43. jährlichen J.P. Morgan Healthcare-Konferenz in San Francisco bekannt gegeben. Die Führungskräfte des Unternehmens werden am Montag, den 13. Januar 2025, um 12:00 Uhr ET / 9:00 Uhr PT eine Präsentation halten.
Auf die Präsentation folgt eine Q&A-Session, die um 12:20 Uhr ET / 9:20 Uhr PT beginnt. Investoren und Interessierte können den Live-Stream über den Bereich Veranstaltungen & Präsentationen auf der Investor-Relations-Website von Sarepta abrufen. Die Aufzeichnung der Präsentation wird für 90 Tage auf der Website verfügbar bleiben. Den Teilnehmern wird geraten, sich frühzeitig zu verbinden, um ausreichend Zeit für eventuelle Software-Downloads zu haben.
- None.
- None.
The presentation will be webcast live under the Events & Presentations section of the investor relations section of Sarepta’s website at https://investorrelations.sarepta.com/events-presentations and will be archived there following the presentation for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.
About Sarepta Therapeutics
Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit www.sarepta.com or follow us on LinkedIn, X, Instagram and Facebook.
Internet Posting of Information
We routinely post information that may be important to investors in the 'For Investors' section of our website at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250106832295/en/
Investor Contact:
Ian Estepan, 617-274-4052
iestepan@sarepta.com
Media Contact:
Tracy Sorrentino, 617-301-8566
tsorrentino@sarepta.com
Source: Sarepta Therapeutics, Inc.
FAQ
When is Sarepta Therapeutics presenting at the 2025 J.P. Morgan Healthcare Conference?
How long will SRPT's 2025 J.P. Morgan Healthcare Conference presentation be available online?
Where can investors watch Sarepta's J.P. Morgan Healthcare Conference presentation?
What time does the Q&A session start for SRPT's presentation at the J.P. Morgan Healthcare Conference?
